Exploring the Cost-Utility of a Biomarker Predicting Persistent Severe Acute Kidney Injury: The Case of C-C Motif Chemokine Ligand 14 (CCL14)

• Váldodahkkit: Echeverri J (Dahkki), Martins R (Dahkki), Harenski K (Dahkki), Kampf JP (Dahkki), McPherson P (Dahkki), Textoris J (Dahkki), Koyner JL (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Dove Medical Press, 2024-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Jorge Echeverri,1 Rui Martins,2,3 Kai Harenski,4 J Patrick Kampf,5 Paul McPherson,5 Julien Textoris,6,7 Jay L Koyner8 1Global Medical Affairs, Baxter Healthcare Corporation, Deerfield, IL, USA; 2University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; 3Health Economi...